Dainippon Sumitomo Pharma shifts the focus back to its core business
Dainippon Sumitomo Pharma puts PE investment aside for now.
Dainippon Sumitomo Pharma puts PE investment aside for now.
Copyright PEI Media
Not for publication, email or dissemination